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 Abstract 
 
Methods to effectively detect multi-locus genetic association are becoming increasingly 
relevant in the genetic dissection of complex trait in humans. Current approaches 
typically consider a limited number of hypotheses, most of which are related to the effect 
of a single locus or of a relatively small number of neighboring loci on a chromosomal 
region. We have developed a novel method that is specifically designed to detect genetic 
association involving multiple disease-susceptibility loci, possibly on different 
chromosomes. Our approach relies on the efficient discovery of patterns comprising 
spatially unrestricted polymorphic markers and on the use of appropriate test statistics to 
evaluate pattern-trait association. Power calculations using multi-locus disease models 
demonstrate significant gain of power by using this method in detecting multi-locus 
genetic association when compared to a standard single marker analysis method. When 
analyzing a Schizophrenia dataset, we confirmed a previously identified gene-gene 
interaction. In addition, a less conspicuous association involving different markers on the 
same two genes was also identified, implicating genetic heterogeneity.  
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 Introduction 
 
Genetic dissection of complex traits in humans has become a major focus in the 
biomedical research community [Lander, et al. 2001] as the majority of common diseases 
with significant public health impact fall in this category. It has been proposed that 
genome-wide association analysis may be the choice of deciphering the non-Mendelian 
inheritance mode of common diseases [Risch and Merikangas 1996]. However, up to 
now there have been limited successes with conventional association studies [Hugot, et 
al. 2001; Rioux, et al. 2001; Tavtigian, et al. 2001], possibly due to the multifactorial 
nature of common diseases. Multi-locus genetic association analysis seems to provide 
increased power to detect multiple susceptibility loci even with moderate sample size 
[Longmate 2001], and thus might be an advantageous alternative for the genetic 
dissection of complex traits in humans.  
Methods for multi-locus association analysis can be classified into two broad 
categories: local multi-locus genetic association analysis and global multi-locus genetic 
association analysis [Hoh and Ott 2003]. Methods for local multi-locus genetic 
association analysis, such as the haplotype-based association test [Puffenberger, et al. 
1994; Terwilliger and Ott 1992] and the haplotype-based Transmission Disequilibrium 
Test (TDT) [Clayton and Jones 1999; Clayton 1999; Dudbridge, et al. 2000; Lazzeroni 
and Lange 1998; Merriman, et al. 1998; Zhao, et al. 2000], usually analyze multiple 
nearby loci jointly. χ2 test of independence is often used to evaluate statistical 
significance of potential association [Spielman, et al. 1993; Terwilliger and Ott 1992]. 
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More recently, a generalized T2 test utilizing multiple markers was proposed as a more 
powerful alternative to χ2 test for association [Xiong, et al. 2002]. Methods for global 
multi-locus genetic association analysis [Hoh and Ott 2003], such as logistic regression 
[Cruickshanks, et al. 1992], sums of single-marker statistics [Hoh, et al. 2000], 
combinatorial partitioning [Nelson, et al. 2001], and data mining [Czika, et al. 2001; 
Flodman, et al. 2001; Toivonen, et al. 2000], focus instead on the detection of multiple 
disease susceptibility loci regardless of their chromosomal locations in the genome. 
Except for the combinatorial partitioning method, existing global multi-locus association 
analysis methods are not designed to systematically search all possible combination of 
loci in order to identify potential marker-trait association. As a result, a particular 
combination of marker loci with significant association to a trait might evade significance 
evaluation and go undetected.  
Several challenges exist for developing such a method for global multi-locus 
association analysis. The foremost challenge arises from the combinatorial nature of the 
problem. Increasing the number of loci used in a genome-wide scan results in the 
exponential growth of possible multi-locus combinations, thus making the computational 
cost of their enumeration prohibitive. The second challenge is how to adjust statistical 
significance for multiple-testing. With tens of millions of multi-locus combinations 
evaluated and with strong correlations among different combinations due to locus 
sharing, proper multiple-testing corrections other than the Bonferroni correction are 
needed to control type I error while retaining power. 
 Pattern discovery-based approaches have been shown to be rather efficient at 
dealing with the combinatorial nature of identifying multi-element associations with 
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analyses of protein motifs and gene expression data [Califano 2000; Rigoutsos and 
Floratos 1998]. Remarkably, a “Market Basket Analysis” (MBA) method, similar to the 
pattern discovery-based methods on sequence analysis and gene expression analysis, has 
been widely used in marketing research to identify association rules among disjointed 
sets of items [Agrawal and Srikant 1994].  
We have developed a pattern discovery-based method to detect both local and 
global multi-locus genetic associations. The method employs an efficient pattern 
discovery algorithm and a pattern-trait association test to assess the statistical 
significance of potential associations. A model to correct pattern significance for multiple 
testing was also developed. In this report, we have applied the pattern discovery-based 
method to both simulated datasets and a real Schizophrenia dataset. Power calculations 
using multi-locus disease models on simulated genotypes on 71 SNP markers 
demonstrated significant gain of power by using this method in detecting multi-locus 
genetic associations when compared to a standard single marker analysis method. When 
analyzing a Schizophrenia dataset, we not only confirmed the original finding of a gene-
gene interaction associated with Schizophrenia [Chumakov, et al. 2002], but also    
identified a potential association involving different alleles on the same two genes that 
had eluded previous detection efforts. Further analysis of this finding implies potential 
genetic heterogeneity. To summarize, our results indicated that the pattern discovery-
based method for detecting multi-locus genetic association could be a useful tool for 
dissecting complex genetic traits in humans, particularly when oligogenic/polygenic 
inheritance and gene-gene interactions are present.   
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 Materials 
Two-Locus Disease Models 
In this report, two-locus disease models [Clerget-Darpoux and Babron 1989; Dizier, et al. 
1994; Fan and Knapp 2003; Xiong, et al. 2002] were chosen for power calculations 
(Table 1). Each disease-causing locus was represented by a bi-allelic marker (marker M1 
for the first locus, marker M2 for the second locus). In the recessive-recessive (R-R) 
model, the presence of homozygote genotypes in both markers (aa for M1, bb for M2) 
was required to confer the disease state (genotype aabb has elevated disease penetrance). 
In the dominant-recessive (D-R) model, homozygote status was only required for marker 
M1 (both genotypes aaBb and aabb have elevated disease penetrance). To emulate the 
genetic complexity of common disease, we selected a high level of penetrance for 
phenocopies and modest penetrance for disease-causing genotype(s) [Gardner, et al. 
1997; Lander and Schork 1994; Wallace, et al. 1996; Xiong, et al. 2002]. The penetrance 
of phenocopies (individuals that are affected but do not have the disease genotype(s) on 
M1 and M2) was set to 10%, while the penetrance of affected genotype was set to 26.4% 
for the D-R model and 44% for the R-R model. 
Real Data 
Genotypes of 28 SNP markers on 454 individuals, including 213 affected individuals and 
241 controls, were obtained from GENSET Corp. (now a subsidiary of Serono, S.A.). Of 
the 28 markers, 8 markers are on chromosome 12 at position 12q24, spanning 115 kb and 
covering the gene D-amino acid oxidase (DAO[MIM124050]) [Chumakov, et al. 2002]. 
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The rest of the 20 markers are on 13q34, spanning 266 kb and covering the 
G72[MIM607408] gene [Chumakov, et al. 2002].  
Simulated Data 
Simulated genotype data were used for power calculation. Genotype data (without phase 
information) on 71 SNP markers were modeled after an actual human population 
[Johnson, et al. 2001]. In particular, 69 SNP markers on five genes were picked to serve 
as disease-unrelated markers (13 markers for gene H19, 11 markers for CASP10, 13 
markers for CASP8, 20 markers for SDF1, and 12 markers for TCF8). Two additional 
markers (M1 and M2) were embedded into each simulated genome, serving as the 
disease-related markers.  
 
Assuming a population-based case-control study design, genotype data were generated de 
novo from a simulation program (Dahlia Nielsen, personal communication) by providing 
values for the following program parameters: haplotype/allele frequencies, penetrance of 
disease-causing genotypes, and penetrance of phenocopies. Phase information and 
haplotype structures were ignored in data analysis. For each of the two disease models 
tested, we evaluated five genotype frequency settings for disease-related markers M1 and 
M2 (Table 1) and two sample sizes (250 cases/250 controls, and 500 cases/500 controls). 
For each simulation condition, which was a combination of disease model, frequency 
setting, and sample size, 500 simulated datasets, each containing genotypes of 71 SNP 
markers, were generated. To derive test rejection level for individual pattern/marker, 500 
simulated datasets were also generated for each simulation condition under the null 
hypothesis, in which the penetrance of phenocopies was used for all possible genotypes.
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 Methods and Results 
Methods 
The pattern discovery-based method for multi-locus genetic association analysis 
Detailed notations on pattern and maximal patterns can be found in Appendix. Briefly, a 
pattern is a sub-matrix π of a data matrix M (individuals as rows and markers as 
columns), identified by a subset of the markers Cπ  (pattern composition) and a subset of 
individuals Sπ  (pattern support), such that the value of each marker X in π across the 
individuals within Sπ  satisfies a predefined equivalence criteria. Figure 1 showed two 
representative patterns (Figure 1B and 1C) embedded in a data matrix (Figure 1A). A 
sub-pattern is generated when one or more individuals (rows) and/or one or more markers 
(columns) are removed from a pattern. A maximal pattern is a pattern that is not a sub-
pattern of any other pattern in the dataset. Given that a pattern is always more statistically 
significant than any of its sub-patterns [Califano 2000], only maximal patterns are 
identified in this method [Rigoutsos and Floratos 1998]. 
The pattern discovery-based method for association analysis was based on an 
efficient deterministic algorithm [Califano 2000], which ensures that all maximal patterns 
satisfying a single parameter, support constraint, will be discovered. The support 
constraint, minj , specifies the minimum support size for any reported pattern, regardless 
of the pattern composition. The algorithm starts by first identifying all individual markers 
(pattern seeds) whose corresponding genotype(s) satisfy a specified minj . Subsequently, 
pattern seeds are merged systematically in an iterative merging process, in which sub-
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patterns and patterns that are no longer satisfying the support constraint minj  are 
removed, resulting in an exhaustive list of maximal patterns.  
In the context of a case/control study, we seek maximal patterns that exhibit a 
significantly higher support in cases versus controls. Therefore, our method starts with a 
discovery step where maximal patterns are identified in cases only (Detailed explanation 
on this approach can be found in Appendix). Subsequently, each discovered pattern is 
evaluated through an association test statistics that accepts or rejects the null hypothesis 
of no distribution difference in the pattern support between cases and controls. As 
described in detail in the Appendix, the association test statistics for patterns is a 
goodness-of-fit test similar to the χ2 test. In the test, the presence or absence of a pattern 
in cases and controls are counted. As a result, only one degree of freedom is available for 
the test statistics. A reference distribution with only one degree of freedom that 
summarizes test statistics for all patterns regardless of the marker composition or support 
in a pattern, is generated with a Monte Carlo process, in which 1,000~10,000 simulated 
datasets are synthesized by randomly picking cases from the pool of actual cases and 
controls. The same Monte Carlo process is also used to implement a proper multiple 
testing correction for this method to control family-wise type I error.  
 
Estimation of test rejection level for individual pattern/marker  
The test rejection level for individual pattern or marker (the latter for the χ2-based single 
marker test) was estimated to achieve a family-wise type I error rate of 0.05. To study the 
correlation between power and the pattern support constraint minj , test rejection level for 
individual pattern was established for every value of minj . More specifically, at each 
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value j of minj  within an arbitrary window, typically between 20% and 40% of the 
sample size for cases, the test rejection levels for individual pattern for a particular 
combination of sample size and genotype frequency were estimated in the following 
manner: First, pattern discovery was performed on each of the 500 datasets under the null 
hypothesis. Second, a reference distribution for pattern significance Dj was constructed 
with test statistics obtained from patterns. Third, after pattern with the smallest P value 
was registered for each dataset, the smallest P values obtained from all 500 datasets were 
sorted in ascending order. Last, the largest P value within the top 5 percentile of the sort 
was chosen as the test rejection level ( jα ) for individual pattern for the specified value j 
of minj . The mean and standard deviation of the test rejection level was then estimated 
from all simulation conditions for a given sample size. An identical process (without the 
support stratification) was used to obtain the significance threshold 0α  for the single-
marker χ2 test. 
 
Power calculation 
Different procedures were used to estimate power for the pattern discovery-based method 
and for the single marker χ2 test. For the pattern discovery-based method, power was first 
calculated as a function of the pattern support constraint minj . Specifically, under each 
simulation condition the following procedure was used: At each value j of minj  within an 
arbitrary window, typically between 20% and 40% of the case sample size, pattern 
discovery was performed on each of the 500 datasets. Resulting patterns identified at 
each j were assigned P values using the corresponding reference distribution Dj and were 
deemed “significant” if their P values were less than jα . A true positive call was 
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registered for a dataset if the pattern with only the disease genotypes for markers M1 and 
M2 was found significant. Power was defined as the percentage of true positive calls for a 
given value j of minj  among all 500 datasets. The maximal power achieved under all 
values of minj  was used as the representative power for the pattern discovery-based 
method under that particular simulation condition.  
 
For the single marker χ2 test, the set of markers with P value less than 0α  was selected. If 
both markers M1 and M2 were in that set, the test on that dataset was considered a true 
positive. The overall power of the single marker χ2 test was again defined as the 
percentage of the true positive calls. 
 
χ2-Based Single Marker Association Test 
For the purpose of comparison, a χ2-based single marker association test was performed 
both to assess the statistical power of the approach based on simulated data and in the 
analysis of a Schizophrenia data set. In the test, a 2x2 table was created for each genotype 
of a marker, with the present or absent of the genotype in corresponding two rows and 
with case and control as two columns. χ2 statistics and corresponding P value were then 
obtained. (Please note: This χ2 test is slightly different from the one preformed in 
[Chumakov, et al. 2002]. In [Chumakov, et al. 2002], χ2 test was performed separately in 
French Canadian and Russian populations. In this analysis, χ2 test was performed on the 
combined population.) 
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Results 
Estimation of Test Rejection Level for Individual Marker/Pattern  
Before estimating power, test rejection level for individual marker or pattern was 
established from genotype data simulated on 71 markers under the null hypothesis. The 
null hypothesis was simulated under two different sample sizes (250 cases/250 controls 
and 500 cases/500 controls) and ten genotype frequencies for marker M1 and M2 (five 
genotype frequencies as in the D-R model and five as in the R-R model). Test rejection 
levels for individual marker and pattern were obtained at each value j of minj  between 
20% and 40% of the case sample size. Table 2 shows the mean test rejection levels for 
single marker and pattern with minj set to 20% of the case sample size. For the single 
marker χ2 test, test rejection levels are fairly consistent across different simulation 
conditions. The single marker test rejection levels under both sample sizes (P=1.01E-3 
and P=1.08E-3 for 250 cases and 500 cases, respectively) were less conservative than the 
Bonferroni correction, which would yields a significance level of 7.2E-4, presumably due 
to haplotype structures embedded in the simulation model. Similar observations were 
made on the test rejection level for single pattern with minj set to 20% of the case sample 
size (P=1.19E-4 and P=1.05E-4 for 250 cases and 500 cases, respectively). With on 
average 4,000 patterns identified from each simulated dataset with minj  set to 20% of the 
case sample size, Bonferroni correction would have yielded a significant threshold of 
1.25E-5.  
 
Power Calculation and Comparison 
12 
A simulation-based power calculation was performed to evaluate the power of the pattern 
discovery-based method on multi-locus association analysis. For comparison purposes, 
the power of a χ2-based single marker test was also analyzed. Power was analyzed with 
genotypes of 71 SNP markers for two selected disease models (Dominant-Recessive and 
Recessive-Recessive) as a function of the sample size and the genotype frequencies of 
affected markers M1 and M2. Because the power of the pattern discovery-based method 
may vary when pattern discovery is performed with different pattern support constraint 
minj , the correlation between power and minj  was analyzed prior to the power 
comparison. 
Figure 2 shows the correlation between power and pattern support constraint minj  
under 20 different simulation conditions, with each condition representing a particular 
combination of sample size, disease model, and frequency of affected genotypes. 
Correlations with 250 cases and 250 controls are shown in Figure 2A, while correlations 
with sample size of 500 cases and 500 controls are shown in Figure 2B. As expected, a 
general trend of power reduction was observed with the increase of minj  under most 
simulation conditions, although the onset and the magnitude of power reduction varied 
under different conditions (Figure 2). The onset of power reduction is strongly correlated 
with the frequency of affected genotypes as higher frequency leads to a larger proportion 
of affected individuals that share the affected genotypes.  
No significant power difference was observed between the two disease models, 
suggesting that the pattern discovery-based method might perform similarly across 
genetic models, which is advantageous since the underline genetic models for common 
diseases are normally not known.  
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While under many simulation conditions the power has demonstrated a monotonic 
decrease with the increase of minj (For example: Figure 2B, conditions with affected 
genotype frequency of 0.143, 0.206, and 0.28 for the D-R disease model, and conditions 
with affected genotype frequency of 0.08, 0.115, and 0.156 for the R-R disease model), a 
power peak was nevertheless evident under the dominant-recessive model (Figure 2A, 
conditions with affected genotype frequency of 0.143, 0.206, and 0.28). For example, 
with affected genotype frequency of 0.206 and 250 cases under the dominant-recessive 
model, the maximal power (87%) was achieved with =72 (Table 3, row 4). The fact 
that a loss of power was observed with 
optimalj
minj  smaller than the  confirmed our 
hypothesis that setting 
optimalj
minj  smaller than an empirically estimated  for the pattern 
discovery step of the method is detrimental, because a smaller 
optimalj
minj  would yield a larger 
number of total patterns, which in turn would lead to lower test rejection level for 
individual pattern due to multiple testing correction.  
The optimal support constraint  was identified for all simulation conditions 
with 
optimalj
minj  varying between 20% and 40% of the case sample size (Table 3, Figure 2). 
Because no clear power peak was visible for two of the smallest frequencies (5.1% and 
9.1% for D-R, 2.9% and 5.1% for R-R) of affected genotypes under both disease models 
and both sample sizes, we further reduced minj  to 10% of the case sample size to examine 
the possibility that larger power can be recovered with smaller minj . Indeed larger power 
was obtained in all eight simulation conditions, resulting in new  for each condition 
(Table 3, rows 1, 2, 6, and 7). The best power identified under each simulation condition 
optimalj
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(Table 3) was used for power comparison between the pattern discovery-based method 
for association analysis and the single marker χ2 test (Figure 3).  
Under all 20 simulation conditions, the pattern discovery-based methods 
consistently outperformed the single marker χ2 test in terms of absolute power (Figure 
3A and 3C). While power for both methods improved with the larger sample size (500 vs. 
250) and higher affected genotype frequency, the gain of power by the pattern discovery-
based method over the single marker association test is not uniform (Figure 3B and 3D). 
Instead, the pattern discovery-based method exhibited the largest gain of power when the 
affected genotype frequency was the smallest. For example, a more than 10 fold power 
increase over the single marker association test at affected genotype frequency of 5.1% 
was observed for the pattern discovery-based method for the D-R disease model with 500 
cases and 500 controls (Figure 3B). In the R-R disease model, a 27 fold power increase at 
affected genotype frequency of 2.9% was observed with 250 cases and 250 controls. On 
the other hand, there were less than 2 fold increases of power by the pattern discovery-
based method over the single marker association test with affected genotype frequencies 
of 28% for the D-R model and of 15.6% for the R-R model. Differential power gain by 
the pattern discovery-based method over the single marker test was also observed at two 
sample sizes tested. As shown in Figure 3B and 3D, except for the simulation condition 
with affected genotype frequency of 5.1% in the D-R model, larger power ratios between 
these two methods were consistently observed with the sample size of 250 cases and 250 
controls in comparison with the sample size of 500 cases and 500 controls. Taking 
together, these observations indicate that the pattern discovery-based method is able to 
detect disease association under all designed simulation conditions and might have 
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significant advantage over the traditional single marker association test when the affected 
genotype frequency is small. 
 
Detecting Gene-Gene Interactions in a Schizophrenia Dataset 
In order to further assess the utility of the pattern discovery-based method for association 
analysis, we applied it to a well-characterized dataset collected from a case/control 
association study on Schizophrenia. The dataset contained genotypes for 28 SNP markers 
spanning 115 kb at 12q24 (8 markers) and 266 kb at 13q34 (20 markers). Using 
traditional association tests and functional assays, two interacting susceptibility genes 
were previously identified on these regions of the human genome [Chumakov, et al. 
2002]: G72 on chromosome 13, and D-amino acid oxidase (DAO) on chromosome 12. 
Specifically, markers M-22 on chromosome 13 and MDAAO-6 on chromosome 12 were 
found to show significant association with the disease when considered together. Because 
markers in this dataset are distributed over two different chromosomal regions and the 
associated markers are known, this dataset is ideal to test the pattern discovery-based 
method for multi-locus genetic association.   
To establish a baseline, we used a frequency-based single-marker χ2 test to detect 
genotype distribution bias in the dataset, similar to what was described [Chumakov, et al. 
2002]. Consistent with previous findings [Chumakov, et al. 2002], three markers were 
found to be statistically significant (P <= 0.01) with the single marker association test 
before multiple-testing correction (MDAAO-6: P=9.62e-4; M-22: P=5.84e-3; MDAAO-
5: P=7.71e-3). With Bonferroni correction for multiple-testing to achieve a family-wise 
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type I error of 0.05 (test rejection level for individual marker is 0.00183), however, only 
MDAAO-6 remained significant.  
 The pattern discovery-based method was applied to both the real dataset and 
5,000 simulated datasets. Because the true statistical power for this method on this real 
dataset is unknown, we used the number of significant patterns as a representation of 
power to estimate the value of the optimal support constraint  (the Appendix). 
 was estimated to be 24, roughly 10% of the case population under study (Figure 
4). With the association test rejection level for individual pattern calculated at 9.49e-5 
with 
optimalj
optimalj
minj = , only two out of 5,952 identified patterns were found to be significantly 
associated with Schizophrenia. None of the sub-patterns of those two significant patterns 
were significantly associated with Schizophrenia.  
optimalj
The most significant pattern (Pattern A in Table 4A) included two markers, 
marker MDAAO-6 on chromosome 12, and M-22 on chromosome 13, the same two 
markers that were previously identified in a multi-locus association with Schizophrenia 
[Chumakov, et al. 2002]. Relative risk analysis using a Crude Odds Ratio test 
[Hennekens and Buring 1987] on pattern A provided additional support to the 
significance of the association (Table 4A, odds ratio=4.54, confidence interval: 2.3-9.1). 
The second significant pattern (Pattern B in Table 4A) included seven markers, one 
marker (marker MDAAO-7) on chromosome 12, and markers M-11, M-12, M-13, M-14, 
M-15, and M-16 (M-11~M-16) on chromosome 13. None of the markers in this pattern 
was significant by itself when assessed with the single-marker χ2 test (Table 4A). The 
significance of the association was only found when they were considered together in a 
single pattern (P=7.33e-5). Again, crude odds ratio analysis indicated that pattern B 
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carried significant relative risk for Schizophrenia (odds ratio=15, 95% confidence 
internal: 3.5-65). 
 Despite the fact that marker M-22 and markers M-11~M-16 are co-localized in a 
266 kb region on chromosome 13, they belong to different LD blocks: Markers M-12~M-
16 form a single LD block (D’ between markers >0.9), while M-22 is in a LD block with 
M-23 and M-24 [Chumakov, et al. 2002]. Similarly, though barely 9.7 kb apart, markers 
MDAAO-6 and MDAAO-7 are not in strong linkage disequilibrium (D’=0.55). 
Combined with the fact that markers in both patterns were mapped to the same two genes 
(DAO and G72), these observations prompted us to ask the following question: Do those 
two patterns indicate independent patterns of co-segregation, perhaps due to genetic 
heterogeneity? If that was the case, one would expect that the affected individuals 
carrying the MDAAO-6/M-22 mutations would be relatively disjoint from the affected 
individuals carrying the M-11~M-16/MDAAO-7 mutations. Indeed, when individuals 
participated in pattern A and B are tallied, only three cases and none of the controls 
participated in both patterns (Table 4B). To calculate the combined relative risk on DAO 
and G72 loci as characterized by Pattern A or Pattern B for Schizophrenia, we 
constructed a χ2 test (Table 4C) in which individuals carrying either of the two patterns 
or none of the two patterns were counted in cases and in controls. A significant P value 
(P=8.67E-11) suggested that at least two independent patterns of co-segregation might be 
responsible for the susceptibility on the DAO and G72 loci. 
18 
 Discussion 
 
The pattern discovery-based method for multi-locus genetic association has several novel 
properties. First, unlike current local multi-locus analysis methods [Lazzeroni and Lange 
1998; Puffenberger, et al. 1994; Terwilliger and Ott 1992], which are usually restricted to 
nearby markers, a pattern can contain markers located far apart on a chromosome or even 
on different chromosomes. It is, therefore, ideally suited for the identification of all 
possible co-segregations in the genome, which might be a powerful way to effectively 
locate multiple disease susceptibility genes responsible for common diseases. Second, 
comparing to other global multi-locus analysis methods such as the logistic regression 
analysis [Cruickshanks, et al. 1992] and the sum of single-marker statistics [Hoh, et al. 
2000], our method does not rely on single-locus effects. Instead, it can detect both single-
locus and multi-locus effects simultaneously. Third, the deterministic nature of the 
algorithm guarantees the discovery of all maximal patterns, thus reducing the risk of 
missing important multi-locus association. The identification of the second significant 
association involving seven markers from the Schizophrenia dataset by the pattern 
discovery-based method supports this notion.  Fourth, this approach is model-
independent and can be applied to various study designs such as case/control and family-
based studies, making it a general method for genetic analysis. 
One of the most significant challenges for the pattern discovery-based method is 
how to correct for multiple testing. For example, even a moderate sized dataset with a 
few hundred markers can produce tens of thousands of highly correlated patterns, 
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Bonferroni correction is clearly not appropriate for it. Instead, we have employed a 
Monte Carlo process [Lazzeroni and Lange 1998; McIntyre, et al. 2000] to empirically 
estimate the appropriate significance threshold for the single pattern association test so 
that the family-wise type I error can be controlled to an acceptable level. Furthermore, by 
estimating the significance threshold for single pattern at each minj , our method further 
limits the detrimental effect of random patterns with small support, as demonstrated in 
power calculation, where the power of our method actually decreased when minj  was less 
than  under several simulation conditions.  optimalj
  Under two disease models we demonstrated that our pattern discovery-based 
multi-locus association test has superior power to detect multi-locus association when 
compared to a single marker association test. To properly generate simulation datasets, 
several assumptions reflecting the underlying genetic complexity of common diseases 
were implemented, including factors such as incomplete penetrance, polygenic 
inheritance, and high frequency of disease-causing alleles, etc.. In both disease models, 
polygenic inheritance was required for modestly elevated but partial disease penetrance. 
A rather substantial (10%) penetrance for phenocopies was used. On those two markers 
representing the susceptibility loci, both affected alleles were common alleles with high 
allele frequencies (from 23% to 75%, depending on the disease model and simulation 
condition). By demonstrating strong power under these simulation conditions, we argue 
that the pattern discovery-based method is a valid approach for detecting associations of 
genetic factors to complex traits. Furthermore, simulations suggested that the pattern 
discovery-based method gained most power with relatively small sample sizes and low 
allele frequencies for associated allele.  
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 The discovery of two significant patterns from the Schizophrenia dataset provided 
a good example to illustrate some of the advantages of using the pattern discovery-based 
method. Not only did our method confirmed original finding of a gene-gene interaction 
(Table 4, pattern A) [Chumakov, et al. 2002], it also detected a potential association 
(Table 4, pattern B) that was not identified previously. Interestingly, none of the markers 
in pattern B was significant individually, only by analyzing all possible combinations of 
these markers were we able to identify the potential association. It is critical to confirm 
the genetic association suggested by pattern B with an independent dataset in future 
studies and with functional assays.  
 In summary, our analysis suggested that the pattern discovery-based method for 
multi-locus genetic association analysis is a potentially powerful test that can be applied 
to the dissection of complex genetic traits in humans. When compared to a standard 
single marker association test, the pattern discovery based method appears to have more 
power at detecting susceptibility loci, especially when multiple disease-causing genes are 
present. In order to use the method in genome-wide association studies, the efficiency of 
the pattern discovery algorithm needs to be improved so that tens of thousands of markers 
can be readily accommodated in a single search. At the present, a divide-and-conquer 
approach is designed to handle large dataset collected from genome-wide association 
studies. With proper heuristics, we hope to be able to reduce the search space for 
maximal patterns while retaining power. 
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Appendix 
Definitions 
Genotypic data for I individuals on N genomic markers can be arranged in a 
matrix { },i mM µ= , where each row 1≤ i ≤ I corresponds to an individual and each column 
1 ≤ m ≤ N corresponds to a marker (SNP or microsatellite, for example). Cell ,i mµ  
contains the genotype of the m-th marker on the i-th individual. Henceforth, a pattern on 
this data set shall be defined as a sub-matrix π of M, identified by a subset of the markers 
Cπ  (pattern composition) and a subset of individuals Sπ  (pattern support), such that the 
value of each marker X in π across the individuals within Sπ  satisfies a predefined 
equivalence criteria. In this work we use “identity” (i.e., the marker values for X must be 
identical across all the individuals contained in the pattern support set) as the equivalence 
criteria, although more complex equivalence criteria are also possible (e.g., for dealing 
with microsatellite markers). 
A pattern π is called a jk pattern if |Sπ| = j and |Cπ| = k. Such a pattern is said to 
“have support j”. Depending on the nature of the genomic regions used for each 
individual (single or paired chromosomes), a pattern can be further categorized as allelic 
or genotypic. Allelic patterns are made up of chromosomal alleles, while genotypic 
patterns comprise di-allelic genotypes. An allelic pattern whose constituent markers are 
co-located on the same chromosome is equivalent to a haplotype. The definition of a 
pattern is illustrated in Figure 1 with a data matrix of eight individuals genotyped at nine 
single nucleotide polymorphisms (SNPs). Two genotypic patterns are shown. The first 
one (A, shown with italics on a green background in Figures 1A and 1B) has composition 
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{ }1 4 8, ,AC M M M=  and support { }3 4 6, ,AS I I I= . The second pattern (B, shown as 
boldface on a yellow background in Figures 1A and 1C) has composition 
{ }3 5 6 9, , ,BC M M M M=  and support { }1 2 5 7 8, , , ,BS I I I I I= . 
Removal from a pattern of one or more individuals (rows) and/or one or more 
markers (columns) will result in a new sub-matrix that is also a pattern. The latter will be 
called a sub-pattern of the former. For a pattern, the number of its possible sub-patterns is 
exponential both in the size of its support and its composition. Given that a pattern is 
always more statistically significant than any of its sub-patterns [Califano 2000], it is 
desirable to detect only maximal patterns [Rigoutsos and Floratos 1998]. A pattern is 
deemed maximal if it is not a sub-pattern of any other pattern in the dataset. For instance, 
both patterns A and B in Fig. 1 are maximal. However pattern C, with support 
{ }3 6,CS I I=  and composition { }1 4CC M M= , is not maximal because it is a sub-pattern 
of B obtained by removing I4 from its support and M8 from its composition. 
 
A Pattern Discovery-Based Multi-Locus Association Test 
Many pattern discovery algorithms are available both of a deterministic [Califano 2000; 
Jonassen 1997; Rigoutsos and Floratos 1998] and statistical [Bailey and Elkan 1994; 
Neuwald and Green 1994] nature. In this paper, we adapted one of the most efficient 
deterministic algorithms [Califano 2000] for use on genotypic data. The deterministic 
nature of the algorithm guarantees that all maximal patterns satisfying two parameters, 
support constraint and composition constraint, will be discovered. The support constraint, 
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minj , specifies the minimum support size for any reported pattern. The composition 
constraint, , specifies the minimum size of composition for any reported pattern.  mink
Because their values impact overall running time,  and mink minj  should be set 
prudently, balancing the need to discover as many significant patterns as possible with 
tolerance for computational performance. In the analysis of genotypic data, we set  to 
1 in order to capture single-marker patterns, effectively leaving the support constraint as 
the only parameter for the pattern discovery algorithm. The value of the support 
constraint, 
mink
minj , is empirically estimated, taking into account study-related and 
performance-related issues. 
Maximal patterns are identified in the following algorithmic steps: (1) The 
formation of seed pattern. A seed pattern is a maximal pattern satisfying minj  with only 
one marker. (2) The formation of maximal pattern. Seed patterns are merged to form 
maximal patterns satisfying minj  with more than one marker. Sub-patterns and patterns 
that no longer satisfy minj  are removed from the merging process. By managing the 
merging process based on similarities among seed patterns, our algorithm rapidly 
identifies all qualifying maximal patterns without exploring all possible combinations 
among seed patterns. The optimality of such procedure has been described [Califano 
2000]. 
In the context of a case/control study, we are seeking maximal patterns that 
exhibit a significantly higher support in the case versus the control group. Therefore, our 
method commences by a discovery step where maximal patterns are only identified in 
cases (the case-only approach), which is followed by significance evaluation  through an 
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association test statistics that accept or reject the null hypothesis of no distribution 
difference in the pattern support between cases and controls. Comparing to an alternative 
approach in which patterns are discovered in cases plus controls and then evaluated in 
cases against controls (the case+control approach), the case-only approach has the 
following advantages: (1) Better performance. The smaller sample size of the case-only 
approach results in less maximal patterns and less computation. (2) Lower false negative 
rate. As shown in the Results section, the power of this pattern discovery-based 
association test is directly correlated with the pattern support constraint. Because the 
pattern support constraint for case-only patterns can be set much lower than the support 
constraint for case-control patterns due to the smaller sample size in case-only approach, 
better power can be achieved with the case-only approach. (3) Broader maximal pattern 
coverage. It can be shown that while all maximal patterns identified in the cases are 
maximal in cases+controls, not all maximal patterns identified in cases+controls are 
maximal in cases only. 
In the test statistic, a 2x2 contingency table is constructed with one column for 
cases and one for controls. Cells in the first row of the table register supports of a pattern 
in cases and in controls. Cells in the second row register the numbers of cases and 
controls that are genotyped on markers in a pattern but do not contain the pattern. 
Alternatively, a 2xn contingency table can also be used with n-1 degree of freedom and 
with n observed genotype/allele combinations among markers in a pattern. A goodness-
of-fit test similar to the χ2 test is then performed. P values are derived from a reference 
distribution that is generated with a Monte Carlo permutation process. In the Monte Carlo 
process, typically 1,000~10,000 simulated datasets are synthesized by randomly picking 
25 
cases from the pool of actual cases and controls. Pattern discovery is then performed on 
each simulated dataset with the same constraint parameters  and mink minj  used in actual 
dataset. A reference distribution is subsequently generated from tallies of test statistics 
obtained from each simulation.  
One serious challenge for our approach is the multiple-testing problem. Even a 
moderate sized dataset with just a few hundred markers can contain tens of thousands of 
maximal patterns, many of which can be spurious associations. Although Bonferroni 
correction is routinely used to estimate the test rejection level for individual marker (αi) 
so that the family-wise type I error (α) is controlled (normally to 5%), it is too 
conservative for patterns (as shown below in Results), because of extensive correlations 
among patterns due to marker sharing.  
To properly estimate αi,, we again used outputs obtained from the Monte Carlo 
simulation process from which the reference distribution for test statistics is produced for 
a target dataset. Assuming the null hypothesis for all of the simulated datasets, a family-
wise type I error rate of 0.05 means that significant patterns appear in no more than 5% of 
the simulated datasets. Patterns were discovered within each simulated dataset and were 
assigned P values according to the reference distribution discussed above. The smallest P 
value from each dataset was ordered again in ascending order for all simulated datasets. 
The largest P value at the top 5 percentile was declared the test rejection level for 
individual pattern.  
In summary, on a dataset collected from a case-control study, the pattern 
discovery-based association test containing the following steps: (1) Maximal patterns are 
identified from the case dataset with properly chosen minj ; (2) Maximal patterns are 
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evaluated for significant association using a goodness-of-fit statistical test under the null 
hypothesis that both cases and controls are from the same sample population. Pattern 
significance is adjusted for multiple-testing with simulation. 
 
Estimating  optimalj
Selecting an appropriate minj  for pattern discovery is an interesting problem of its own 
right. While choosing a large value for minj  can significantly reduce the computation 
required to identify maximal patterns, it can also adversely affect the power of the pattern 
discovery-based association test: a large minj  value can cause true associations with 
smaller representations in the sampled population to be missed. On the other hand, 
choosing a very small minj  can be detrimental as well: computationally, the number of 
maximal patterns increases exponentially as minj  decreases; statistically, multiple testing 
correction drives the threshold for type I error substantially lower with a small minj , thus 
rendering many patterns insignificant, including (potentially) some patterns that may 
correspond to real disease associations. The choosing of minj  is also related to the study 
design, from which the dataset is collected. Consider, for example, a case/control study 
involving 100 cases and 100 controls with a hypothetical 0.0056 threshold for test 
rejection level for individual pattern. Assume further that pattern significance is to be 
evaluated using a χ2 test comparing the support of the pattern in the case population 
versus the control population. If a pattern is expected to appear by chance alone in at least 
1 control, then that pattern would need to have a support level of at least 10 within the 
case group in order to clear the 0.0056 significance threshold. Under these assumptions, 
27 
if we were to use the pattern discovery-based method to discover patterns within the case 
group, it would make little sense to set minj  to a value less than 10: Doing so would be 
detrimental as it would only increase the amount of computation required without adding 
any new significant patterns.  
When the underlying disease model is known, simulations can be used to identify 
a value  (the optimal optimalj minj ) that maximizes power because correlations between 
minj  and power can be systematically established, as shown in Results. However, when 
the disease model is unknown, power cannot be formally established by simulation. In 
such cases, other criteria have to be used to estimate the . For the Schizophrenia 
dataset, we empirically estimate  as the support level for which the highest number 
of significant patterns is found. This heuristic is designed to maximize the number of 
candidate associations between genetic factors and the complex trait under investigation.  
optimalj
optimalj
At each value j of minj  within an arbitrary window, typically between 5% and 
40% of the case sample size, the test rejection level for individual pattern and reference 
distribution (αj and Dj , respectively) are established with a Monte Carlo process. The 
selection of the arbitrary window is based on the following two factors: (1) the minimal 
expected support of a true association ( minj  = 5% of the case sample size means that the 
smallest representation of a true association our method can detect is 5% of the case 
population), and (2) computational efficiency. At each value j of minj  within the window, 
patterns are identified from the real dataset and evaluated against the corresponding 
reference distribution.  is the largest optimalj minj to yield the largest number of significant 
patterns. 
28 
 29 
Electronic-Database Information 
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/
30 
Acknowledgment 
The authors would like to thank Drs. Daniel Cohen and Fabio Macciardi for providing 
the GENSET dataset and valuable discussions. We would like to thank Dr. Dahlia 
Nielsen for her simulation program and stimulating discussions. We would also thank Dr. 
Aravinda Chakravarti for many helpful discussions. This work is partially supported by a 
SBIR phase I grant awarded by NCI (1R43CA101432-01). 
 
31 
References 
 
Agrawal R, Srikant A. 1994. Fast algorithms for mining association rules. Proc. 
VLDB:487-499. 
Bailey TL, Elkan C. 1994. Fitting a mixture model by expectation maximization to 
discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2:28-36. 
Califano A. 2000. SPLASH: structural pattern localization analysis by sequential 
histograms. Bioinformatics 16(4):341-357. 
Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim 
H, Bougueleret L, Barry C, Tanaka H, La Rosa P and others. 2002. Genetic 
and physiological data implicating the new human gene G72 and the gene for 
D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 
99(21):13675-13680. 
Clayton D, Jones H. 1999. Transmission/disequilibrium tests for extended marker 
haplotypes. Am J Hum Genet 65(4):1161-1169. 
Clayton DG. 1999. A generalization of the transmission/disequilibrium test for 
uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177. 
Clerget-Darpoux F, Babron MC. 1989. Testing genet-ic 
models for IDDM by the MASC method. Genet Epidemiol. 6:59-64. 
Cruickshanks KJ, Vadheim CM, Moss SE, Roth MP, Riley WJ, Maclaren NK, 
Langfield D, Sparkes RS, Klein R, Rotter JI. 1992. Genetic marker 
associations with proliferative retinopathy in persons diagnosed with 
diabetes before 30 yr of age. Diabetes 41(7):879-885. 
32 
Czika WA, Weir BS, Edwards SR, Thompson RW, Nielsen DM, Brocklebank JC, 
Zinkus C, Martin ER, Hobler KE. 2001. Applying data mining techniques to 
the mapping of complex disease genes. Genet Epidemiol. 21(Suppl 1):S435-
S440. 
Devlin B, Risch N. 1995. A comparison of linkage disequilibrium measures for fine-
scale mapping. Genomics 29(2):311-322. 
Dizier MH, Babron MC, Clerget-Darpoux F. 1994. Interactive effect of two 
candidate genes in a disease: Extension of the marker-association-segregation 
χ2 method. Am J Hum Genet 55:1042-1049. 
Dudbridge F, Koeleman BPC, Todd JA, Clayton DG. 2000. Unbiased application of 
the transmission/disequilibrium test to multilocus haplotypes. Am J Hum 
Genet 66:2009-2012. 
Fan R, Knapp M. 2003. Genome association studies of complex diseases by case-
control designs. Am J Hum Genet 72:850-868. 
Flodman P, Macula AJ, Spence MA, Torney DC. 2001. Preliminary implementation 
of new data mining techniques for the analysis of simulation data from 
Genetic Analysis Workshop 12: problem 2. Genet Epidemiol. 21(Suppl 
1):S390-S395. 
Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. 1997. A new locus for 
hemiplegic migraine maps to chromosome 1q31. Neurology 49(5):1231-1238. 
Hennekens CH, Buring JE. 1987. Measures of disease frequency and association. 
Toronto: Little, Brown. p 54-98. 
33 
Hoh J, Ott J. 2003. Mathematical multi-locus approaches to localizing complex 
human trait genes. Nat Rev Genet 4:704-709. 
Hoh J, Wille A, Zee R, Cheng S, Reynolds R, Lindpaintner K, Ott J. 2000. Selecting 
SNPs in two-stage analysis of disease association data: a model-free 
approach. Ann Hum Genet 64(5):413-417. 
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, 
Tysk C, O'Morain CA, Gassull M and others. 2001. Association of NOD2 
leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 
411(6837):599-603. 
Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, 
Cordell HJ, Eaves IA, Dudbridge F and others. 2001. Haplotype tagging for 
the identification of common disease genes. Nat Genet 29(2):233-237. 
Jonassen I. 1997. Efficient discovery of conserved patterns using a pattern graph. 
CABIOS 13:509-522. 
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, 
Dewar K, Doyle M, FitzHugh W and others. 2001. Initial sequencing and 
analysis of the human genome. Nature 409(6822):860-921. 
Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 
265(5181):2037-2048. 
Lazzeroni LC, Lange K. 1998. A conditional inference framework for extending the 
transmission/disequilibrium test. Hum Hered 48(2):67-81. 
Longmate JA. 2001. Complexity and power in case-control association studies. Am J 
Hum Genet 68(5):1229-1237. 
34 
McIntyre LM, Martin ER, Simonsen KL, Kaplan NL. 2000. Circumventing multiple 
testing: a multilocus Monte Carlo approach to testing for association. Genet 
Epidemiol. 19(1):18-29. 
Merriman TR, Eaves IA, Twells RC, Merriman ME, Danoy PA, Muxworthy CE, 
Hunter KM, Cox RD, Cucca F, McKinney PA and others. 1998. 
Transmission of haplotypes of microsatellite markers rather than single 
marker alleles in the mapping of a putative type 1 diabetes susceptibility gene 
(IDDM6). Hum Mol Genet. 7(3):517-524. 
Nelson MR, Kardia SL, Ferrell RE, Sing CF. 2001. A combinatorial partitioning 
method to identify multilocus genotypic partitions that predict quantitative 
trait variation. Genome Res 11(3):458-470. 
Neuwald AF, Green P. 1994. Detecting patterns in protein sequences. J Mol Biol 
239(5):698-712. 
Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, 
Chakravarti A. 1994. A missense mutation of the endothelin-B receptor gene 
in multigenic Hirschsprung's disease. Cell 79(7):1257-1266. 
Rigoutsos I, Floratos A. 1998. Combinatorial pattern discovery in biological 
sequences: The TEIRESIAS algorithm. Bioinformatics 14(1):55-67. 
Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, 
Kocher K, Miller K, Guschwan S and others. 2001. Genetic variation in the 
5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 
29(2):223-228. 
35 
Risch N, Merikangas K. 1996. The future of genetic studies of complex human 
diseases. Science 273(5281):1516-1517. 
Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage 
disequilibrium: the insulin gene region and insulin-dependent diabetes 
mellitus (IDDM). Am J Hum Genet 52(3):506-516. 
Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, 
Carillo AR, Chen Y, Dayananth P and others. 2001. A candidate prostate 
cancer susceptibility gene at chromosome 17p. Nat Genet 27(2):172-180. 
Terwilliger JD, Ott J. 1992. A haplotype-based 'haplotype relative risk' approach to 
detecting allelic associations. Hum Hered 42(6):337-346. 
Toivonen HT, Onkamo P, Vasko K, Ollikainen V, Sevon P, Mannila H, Herr M, 
Kere J. 2000. Data mining applied to linkage disequilibrium mapping. Am J 
Hum Genet 67(1):133-145. 
Wallace R, Berkovic S, Howell R, Sutherland G, Mulley J. 1996. Suggestion of a 
major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet 
33(4):308-312. 
Xiong M, Zhao J, Boerwinkle E. 2002. Generalized T2 test for genome association 
studies. Am J Hum Genet 70(5):1257-1268. 
Zhao HY, Zhang SL, Merikangas KR, Widenauer DB, Sun FZ, Kidd K. 2000. 
Transmission/disequilibrium tests using multiple tightly linked markers. Am 
J Hum Genet 67:936-946. 
 
36 
Tables 
Table 1 Disease models in power calculation. 
 
Bi-allele Frequency 
Model A-B A-b a-B a-b LD (D’)
Frequency 
of Affected 
Genotype(s) 
Population 
Prevalence
D-R 0.485 0.168 0.262 0.085 0.08 0.051 0.108 
D-R 0.4 0.139 0.349 0.113 0.12 0.091 0.115 
D-R 0.314 0.109 0.436 0.141 0.14 0.143 0.123 
D-R 0.228 0.079 0.523 0.169 0.17 0.206 0.134 
D-R 0.143 0.05 0.61 0.197 0.15 0.28 0.146 
R-R 0.24 0.37 0.221 0.169 0.21 0.029 0.110 
R-R 0.224 0.345 0.206 0.226 0.24 0.051 0.117 
R-R 0.207 0.32 0.191 0.282 0.21 0.08 0.127 
R-R 0.191 0.295 0.176 0.339 0.19 0.115 0.139 
R-R 0.175 0.269 0.161 0.395 0.19 0.156 0.153 
D-R represents the dominant-recessive disease model; R-R represents the recessive-
recessive disease model. A-B, A-b, a-B, and a-b represent four possible allele 
combinations for markers M1 (alleles A and a) and M2 (alleles B and b). D’ was 
calculated as described [Devlin and Risch 1995]. “Frequency of Affected Genotype(s)” 
represents the cumulative frequency of disease-causing genotype(s). For the D-R model, 
the disease-causing genotypes are aaBb and aabb. For the R-R model, the disease-
causing genotype is aabb. 
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 Table 2 Estimates of significance thresholds (individual type-I error) used in power 
calculations. 
 
Single Marker Goodness-of-fit Pattern Discovery-Based 
Sample Size 
Mean SD Mean SD 
250 cases/250 controls 1.01E-3 1.63E-4 1.19e-4 2.60e-5 
500 cases/500 controls 1.08E-3 2.29E-4 1.05e-4 4.82e-5 
 
Thresholds are chosen so that the family-wise type I error is 0.05. Values in the “Mean” 
column were obtained by averaging the rejection levels from each of 10 datasets 
generated using the simulation conditions described in the text. For the pattern discovery-
based method, the values displayed are for support constraint minj  equal to 20% of the 
size of the case group. 
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 Table 3  in power calculation. optimalj
250 cases/250 controls 500 cases/500 controls Disease 
Model 
Genotype 
Frequency optimalj  Power optimalj  Power 
D-R 0.051 26 0.04 50 0.27 
D-R 0.091 46 0.24 71 0.71 
D-R 0.143 56 0.60 109 0.99 
D-R 0.206 72 0.87 148 1 
D-R 0.28 90 0.98 182 1 
R-R 0.029 25 0.34 50 0.72 
R-R 0.051 38 0.81 71 0.89 
R-R 0.08 50 1 108 1 
R-R 0.115 72 1 150 0.99 
R-R 0.156 85 1 187 1 
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 Table 4 Gene-gene interactions and genetic heterogeneity detected by two patterns in 
GENSET dataset (only markers in significant pattern were shown). 
A 
Marker Chromosome Genotype Location (base) P value Pattern A Pattern B 
M-11 13 C/C 88,511,524 3.59E-2  x 
M-12 13 A/A 88,535,455 1.28E-2  x 
M-13 13 C/C 88,542,989 7.36E-2  x 
M-14 13 G/G 88,549,446 4.55E-2  x 
M-15 13 A/A 88,551,544 3.59E-2  x 
M-16 13 G/G 88,552,517 2.06E-1  x 
M-22 13 G/G 88,601,302 5.84E-3 x  
MDAAO-6 12 T/T 109,018,154 9.6E-4 x  
MDAAO-7 12 A/A 109,027,872 2.26E-2  x 
       
Case Support     38 24 
Control Support     11 2 
P value     4.64E-5 7.33E-5 
Odds Ratio     4.54 15.17 
Confidence Int.     2.2-9.1 3.5-65.0 
The “x” marks indicate the marker composition for a pattern. 
B 
 Pattern A Only Pattern A and B Pattern B only 
Support in Cases 35 3 21 
Support in Controls 11 0 2 
 
C 
 Case Control 
Individuals with either Pattern A or B 59 13 
Individuals with neither Pattern A nor B 154 228 
 P value=8.67E-11  
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Figures 
Figure 1  Examples of maximal patterns.  
A sample genotype data matrix with 9 SNP markers (M1~M9) on 8 individuals (I1~I8) 
was shown. Genotype is represented as two alleles. Cells corresponding to pattern A or B 
were color-coded. 
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A. Data Matrix 
M1 M2 M3 M4 M5 M6 M7 M8 M9
I1 A/A T/T A/A T/T C/G T/T A/T G/G T/T
I2 G/G A/T A/A C/C C/G T/T A/A G/G T/T
I3 A/G A/A T/T T/C C/C C/T T/T T/G T/G
I4 A/G A/T A/T T/C G/G C/C A/T T/G T/G
I5 G/G A/A A/A T/C C/G T/T A/A T/G T/T
I6 A/G A/T A/A T/C C/C C/T T/T T/G G/G
I7 A/G A/A A/A T/T C/G T/T A/A T/T T/T
I8 G/G A/A A/A T/C C/G T/T A/T T/T T/T  
 
B. Pattern A 
M1 M4 M8
I3 A/G T/C T/G
I4 A/G T/C T/G
I6 A/G T/C T/G  
 
C. Pattern B 
M3 M5 M6 M9
I1 A/A C/G T/T T/T
I2 A/A C/G T/T T/T
I5 A/A C/G T/T T/T
I7 A/A C/G T/T T/T
I8 A/A C/G T/T T/T  
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 Figure 2  Correlation between power and pattern support constraint. 
A. Power was calculated at each pattern support constraint minj  between 50 and 100 
under ten different simulation conditions with sample size of 250 cases and 250 controls. 
B. Power was calculated at each pattern support constraint minj  between 100 and 200 
under ten different simulation conditions with sample size of 500 cases and 500 controls. 
Filled “x” represents affected genotype frequency of 0.051 under the dominant-recessive 
model. Filled circles represent affected genotype frequency of 0.091 under the dominant-
recessive model. Filled diamonds represent affected genotype frequency of 0.143 under 
the dominant-recessive model. Filled triangles represent affected genotype frequency of 
0.206 under the dominant-recessive model. Filled squares represent affected genotype 
frequency of 0.28 under the dominant-recessive model. “x” represents affected genotype 
frequency of 0.029 under the recessive-recessive model. Unfilled circles represent 
affected genotype frequency of 0.051 under the recessive-recessive model. Unfilled 
diamonds represent affected genotype frequency of 0.08 under the recessive-recessive 
model. Unfilled triangles represent affected genotype frequency of 0.115 under the 
recessive-recessive model. Unfilled squares represent affected genotype frequency of 
0.156 under the recessive-recessive model. 
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 Figure 3  Power comparisons between a single marker χ2 test vs. the pattern discovery-
based method. 
Powers were compared between a single marker χ2 test and the pattern discovery-based 
multi-locus association test under two disease models (dominant-recessive in A and B, 
recessive-recessive in C and D). A and C showed the power curves for both methods with 
two sample sizes (250 cases/250 controls and 500 cases/500 controls). B and D showed 
the power ratio between the pattern discovery-based method and the single marker χ2 test 
under corresponding sample sizes. 
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 Figure 4 Estimating the optimal support constraint for the GENSET dataset. 
Significant patterns were identified with the pattern discovery-based method at pattern 
support constraint minj between 15 and 50 from the GENSET dataset. The number of 
significant patterns at each minj was plotted against the minj . The optimal support 
constraint (24) is the largest minj with the largest number of significant patterns. 
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